ClinicalTrials.Veeva

Menu

Biofeedback Therapy Versus Botox Injection in Treatment of Dyssynergic Defecation.

M

Mansoura University

Status and phase

Completed
Phase 4

Conditions

Obstructed Defaecation Syndrome

Treatments

Drug: Botulinum Toxin A (Botox )
Device: Biofeedback therapy

Study type

Interventional

Funder types

Other

Identifiers

NCT06724250
MS.23.090.2539

Details and patient eligibility

About

assessment the Improvement symptoms of obstructed defecation after biofeedback training versus botulinum toxin injection

Full description

This is a randomized controlled trial including 78 patients diagnosed with obstructed defecation syndrome confirmed by detailed history talking, full clinical examination, anorectal manometry and defecography.

Included patients divided into two equal groups: first group ( biofeedback therapy group) patients recieved biofeedback therapy for six sessions over one month, the second group:( botulinum toxin group) received botulinum toxin injection 100 IU in buborectalis muscle.

The primary outcome is improvement of symptoms after one year

Enrollment

78 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients of both genders
  • age of 18 years or older
  • fulfillment of the Rome 3 constipation criteria for the past 3 months, symptom onset as a maximum six months prior to diagnosis, patients suffer from prolonged, incomplete and challenging evacuation

Exclusion criteria

  • Anismus cases with secondary reason for constipation
  • patients who undergone anorectal surgery Patients with colonic inertia
  • conditions that make biofeedback training impossible
  • cases with primary illness causing constipation as hypothyroidism

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

78 participants in 2 patient groups

Biofeedback therapy group
Active Comparator group
Description:
Patients with dyssynergic defecation underwent biofeedback training program in the form of six sessions over one month
Treatment:
Device: Biofeedback therapy
Botox injection group
Active Comparator group
Description:
Participants in this group received 100 international unit of botulinum toxin type A that was injected injections into the puborectalis muscle to alleviate dyssynergic defecation by reducing muscle overactivity and improving coordination.
Treatment:
Drug: Botulinum Toxin A (Botox )

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems